Your browser doesn't support javascript.
loading
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
Trevisi, Letizia; Hernán, Miguel A; Mitnick, Carole D; Khan, Uzma; Seung, Kwonjune J; Rich, Michael L; Bastard, Mathieu; Huerga, Helena; Melikyan, Nara; Atwood, Sidney A; Avaliani, Zaza; Llanos, Felix; Manzur-Ul-Alam, Mohammad; Zarli, Khin; Binegdie, Amsalu Bekele; Adnan, Sana; Melikyan, Arusyak; Gelin, Alain; Isani, Afshan K; Vetushko, Dmitry; Daugarina, Zhenisgul; Nkundanyirazo, Patrick; Putri, Fauziah Asnely; Vilbrun, Charles; Khan, Munira; Hewison, Catherine; Khan, Palwasha Y; Franke, Molly F.
Afiliación
  • Trevisi L; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
  • Hernán MA; CAUSALab, Departments of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
  • Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
  • Khan U; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.
  • Seung KJ; Partners in Health, Boston, Massachusetts.
  • Rich ML; Interactive Research and Development Global, Singapore, Singapore.
  • Bastard M; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
  • Huerga H; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.
  • Melikyan N; Partners in Health, Boston, Massachusetts.
  • Atwood SA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
  • Avaliani Z; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.
  • Llanos F; Partners in Health, Boston, Massachusetts.
  • Manzur-Ul-Alam M; Field Epidemiology Department, Epicentre, Paris, France.
  • Zarli K; Field Epidemiology Department, Epicentre, Paris, France.
  • Binegdie AB; Field Epidemiology Department, Epicentre, Paris, France.
  • Adnan S; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.
  • Melikyan A; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
  • Gelin A; Unidad de Tuberculosis, Hospital Nacional Dos de Mayo, Lima, Peru.
  • Isani AK; Instituto de Investigaciones en Ciencias Biomedicas, Universidad Ricardo Palma, Lima, Peru.
  • Vetushko D; Interactive Research and Development, Dhaka, Bangladesh.
  • Daugarina Z; Médecins sans Frontières, Yangon, Myanmar.
  • Nkundanyirazo P; Department of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Putri FA; Indus Hospital and Health Network, Karachi, Pakistan.
  • Vilbrun C; Médecins sans Frontières, Yerevan, Armenia.
  • Khan M; Zanmi Lasante, Port-au-Prince, Haiti.
  • Hewison C; National Core Research Group, Stop TB Partnership, Islamabad, Pakistan.
  • Khan PY; Republican Scientific and Practical Centre of Pulmonology and Tuberculosis, Minsk, Belarus.
  • Franke MF; Astana City Center of Phthisiopulmonology, Astana, Kazakhstan.
Am J Respir Crit Care Med ; 207(11): 1525-1532, 2023 06 01.
Article en En | MEDLINE | ID: mdl-36802336
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Antituberculosos Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Antituberculosos Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2023 Tipo del documento: Article